RECKITT BENCKISER LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.lysol.com
Clinical Trials
15
Active:0
Completed:15
Trial Phases
5 Phases
Phase 1:4
Phase 2:2
Phase 3:4
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (26.7%)Phase 3
4 (26.7%)Not Applicable
3 (20.0%)Phase 2
2 (13.3%)Phase 4
2 (13.3%)Study to Evaluate the Safety and Tolerability of Mucinex™(Guaifenesin) 600 mg Extended-Release Bi-Layer Tablets in the Treatment of Otherwise Healthy Patients With Symptoms of Cough, Thickened Mucus and Chest Congestion
Phase 4
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: Mucinex™ extended-release (SE)
- First Posted Date
- 2018-10-30
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Reckitt Benckiser LLC
- Target Recruit Count
- 552
- Registration Number
- NCT03725085
Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted
- First Posted Date
- 2018-08-28
- Last Posted Date
- 2019-03-27
- Lead Sponsor
- Reckitt Benckiser LLC
- Target Recruit Count
- 36
- Registration Number
- NCT03649750
Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Reckitt Benckiser LLC
- Target Recruit Count
- 24
- Registration Number
- NCT03642873
Study to Evaluate the Pharmacokinetics of Guaifenesin in Adults and Adolescents
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: Children's Mucinex® Grape Flavor
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2019-06-17
- Lead Sponsor
- Reckitt Benckiser LLC
- Target Recruit Count
- 24
- Registration Number
- NCT03633448
Study to Evaluate the Pharmacokinetics of Mucinex® 1200 mg Extended-Release Tablet
- First Posted Date
- 2018-08-16
- Last Posted Date
- 2019-02-28
- Lead Sponsor
- Reckitt Benckiser LLC
- Target Recruit Count
- 24
- Registration Number
- NCT03633487
- Prev
- 1
- 2
- 3
- Next
News
No news found